Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study.

Ensrud KE, Taylor BC, Peters KW, Gourlay ML, Donaldson MG, Leslie WD, Blackwell TL, Fink HA, Orwoll ES, Schousboe J; Osteoporotic Fractures in Men Study Group.

BMJ. 2014 Jul 3;349:g4120. doi: 10.1136/bmj.g4120.

2.

Performance of FRAX in a cohort of community-dwelling, ambulatory older men: the Osteoporotic Fractures in Men (MrOS) study.

Ettinger B, Ensrud KE, Blackwell T, Curtis JR, Lapidus JA, Orwoll ES; Osteoporotic Fracture in Men (MrOS) Study Research Group.

Osteoporos Int. 2013 Apr;24(4):1185-93. doi: 10.1007/s00198-012-2215-3. Epub 2012 Nov 21.

3.

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.

Leslie WD, Lix LM, Langsetmo L, Berger C, Goltzman D, Hanley DA, Adachi JD, Johansson H, Oden A, McCloskey E, Kanis JA.

Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.

PMID:
21161509
4.

Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines.

Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Dam TT, Curtis JR, Black DM, Bauer DC, Orwoll ES, Cummings SR; Osteoporotic Fractures in Men (MrOS) Study Group.

J Bone Miner Res. 2010 Jul;25(7):1506-11. doi: 10.1002/jbmr.55.

5.

Fracture burden in relation to low bone mineral density and FRAX(®) probability.

Leslie WD, Morin S.

J Clin Densitom. 2011 Jul-Sep;14(3):279-85. doi: 10.1016/j.jocd.2011.04.010. Epub 2011 Jul 1.

PMID:
21723761
6.

WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?

Hillier TA, Cauley JA, Rizzo JH, Pedula KL, Ensrud KE, Bauer DC, Lui LY, Vesco KK, Black DM, Donaldson MG, Leblanc ES, Cummings SR.

J Bone Miner Res. 2011 Aug;26(8):1774-82. doi: 10.1002/jbmr.372.

7.

Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.

Yu R, Leung J, Woo J.

J Am Med Dir Assoc. 2014 Dec;15(12):918-23. doi: 10.1016/j.jamda.2014.07.011. Epub 2014 Sep 24.

PMID:
25262197
8.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

9.

A comparison of three different guidelines for osteoporosis treatment in patients with rheumatoid arthritis in Korea.

Yoon J, Kwon SR, Lim MJ, Joo K, Moon CG, Jang J, Park W.

Korean J Intern Med. 2010 Dec;25(4):436-46. doi: 10.3904/kjim.2010.25.4.436. Epub 2010 Nov 27.

10.

Validation of FRAX without BMD: an age-related analysis of the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-1, 2010).

Kim JW, Koh JM, Park JH, Chang JS.

Bone. 2015 Jun;75:27-31. doi: 10.1016/j.bone.2015.02.013. Epub 2015 Feb 17.

PMID:
25697083
11.

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.

Azagra R, Roca G, Encabo G, Aguyé A, Zwart M, Güell S, Puchol N, Gene E, Casado E, Sancho P, Solà S, Torán P, Iglesias M, Gisbert MC, López-Expósito F, Pujol-Salud J, Fernandez-Hermida Y, Puente A, Rosàs M, Bou V, Antón JJ, Lansdberg G, Martín-Sánchez JC, Díez-Pérez A, Prieto-Alhambra D.

BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204.

12.

High fracture probability with FRAX usually indicates densitometric osteoporosis: implications for clinical practice.

Leslie WD, Majumdar SR, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

Osteoporos Int. 2012 Jan;23(1):391-7. doi: 10.1007/s00198-011-1592-3. Epub 2011 Mar 2.

PMID:
21365460
13.

Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.

Fraser LA, Langsetmo L, Berger C, Ioannidis G, Goltzman D, Adachi JD, Papaioannou A, Josse R, Kovacs CS, Olszynski WP, Towheed T, Hanley DA, Kaiser SM, Prior J, Jamal S, Kreiger N, Brown JP, Johansson H, Oden A, McCloskey E, Kanis JA, Leslie WD; CaMos Research Group.

Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16.

14.

Were you identified to be at high fracture risk by FRAX® before your osteoporotic fracture occurred?

Chen XF, Li XL, Zhang H, Liu GJ.

Clin Rheumatol. 2014 May;33(5):693-8. doi: 10.1007/s10067-014-2533-2. Epub 2014 Feb 28.

PMID:
24577817
15.

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns.

Dawson-Hughes B, Looker AC, Tosteson AN, Johansson H, Kanis JA, Melton LJ 3rd.

Osteoporos Int. 2010 Jan;21(1):41-52. doi: 10.1007/s00198-009-1034-7. Epub 2009 Aug 25.

PMID:
19705046
16.

Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.

Siris ES, Baim S, Nattiv A.

Postgrad Med. 2010 Jan;122(1):82-90. doi: 10.3810/pgm.2010.01.2102. Review.

PMID:
20107292
17.

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A; National Osteoporosis Guideline Group.

Osteoporos Int. 2008 Oct;19(10):1395-408. doi: 10.1007/s00198-008-0712-1. Epub 2008 Aug 28. Erratum in: Osteoporos Int. 2009 Mar;20(3):499-502.

PMID:
18751937
18.

Does osteoporosis therapy invalidate FRAX for fracture prediction?

Leslie WD, Lix LM, Johansson H, Oden A, McCloskey E, Kanis JA; Manitoba Bone Density Program.

J Bone Miner Res. 2012 Jun;27(6):1243-51. doi: 10.1002/jbmr.1582.

19.

A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation.

Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV; Advisory Board of the National Osteoporosis Guideline Group.

Arch Osteoporos. 2016 Dec;11(1):25. doi: 10.1007/s11657-016-0278-z. Epub 2016 Jul 27. Review.

20.

Cost-effective osteoporosis treatment thresholds in Greece.

Makras P, Athanasakis K, Boubouchairopoulou N, Rizou S, Anastasilakis AD, Kyriopoulos J, Lyritis GP.

Osteoporos Int. 2015 Jul;26(7):1949-57. doi: 10.1007/s00198-015-3055-8. Epub 2015 Mar 5.

PMID:
25740208

Supplemental Content

Support Center